ADVARRA, INC.

Advarra Inc. specializes in institutional review board (IRB) services and operational support for clinical research protocols within the life sciences sector. The company provides end-to-end governance infrastructure for human subjects research, including IRB of record functions, protocol review coordination, administrative oversight, and logistical support for multi-site domestic studies. Their technical expertise centers on regulatory compliance frameworks, ethical review workflows, and integrated software platforms such as ClinicalConductor, enabling efficient, auditable, and scalable research oversight. A key differentiator is their deep integration of technology-enabled IRB operations with federal research mandates, ensuring seamless alignment with NIH and HHS requirements for data integrity, participant protection, and study conduct compliance. Advarra maintains a consistent and focused relationship with the Department of Health and Human Services, delivering specialized IRB and research governance services across multiple HHS components, including NIAID and NICHD. Their work supports critical biomedical research initiatives by providing compliant, centralized review mechanisms for complex, multi-site clinical studies, reinforcing HHS’s mission to safeguard research participants while accelerating scientific progress. The contractor’s primary industry focus is Research and Development in the Physical, Engineering, and Life Sciences (NAICS 541715), where they operate at the intersection of regulatory science and clinical trial infrastructure. They also deliver complementary professional services in computer-related systems support and broader scientific technical services, positioning them as a niche provider of integrated research governance solutions rather than a generalist contractor. Advarra Inc. is a small business entity headquartered in Columbia, Maryland, with no federal certifications on record. Their geographic footprint is centered on federal research hubs, and their market positioning reflects a targeted, mission-driven approach to supporting HHS-led biomedical research through specialized, technology-informed IRB and compliance services.